Found 0 matching trials
Pharmacokinetics of Antibiotics in Patients With Cystic Fibrosis Trated With Elexacaftor/Tezacaftor/Ivacaftor (ETI)
N/ACystic fibrosis (CF) is associated with major pharmacokinetic and pharmacod...
OnTrackCF: Engagement, Feasibility, and Acceptability Study
NAThis is a multi-site, nonrandomized study using mixed methods approach to e...
Location
University of Alabama-Birmingham
Prospective Study of Pregnancy in Women With Cystic Fibrosis
N/AIn this study, the investigators aim to evaluate changes in lung function i...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
N/AThe REACH study is for people with CF who do not take cystic fibrosis trans...
Location
The Children's Hospital Alabama, University of Alabama at Birmingham
Response to CFTR Modulators in CF Patients Under 18 Years
N/ACFTR modulators should improve the prognosis of Cystic Fibrosis. Identifyin...
Location
Sermet-Gaudelus Isabelle
Trikafta in Cystic Fibrosis Patients
PHASE2This clinical study will enroll 42 participants without the F508del mutatio...
Location
University of Alabama Cystic Fibrosis Research Center
Impact of Triple Combination CFTR Therapy on Sinus Disease.
N/AThe study's main goal is to observe how effective elexacaftor-tezacaftor-iv...
Location
National Jewish Health
Real Life Evaluation of the Multi-organ Effects of Lumacaftor/Ivacaftor on F508del Homozygous Cystic Fibrosis Patients.
N/ABackground: Lumacaftor/Ivacaftor (LUM-IVA), a CFTR corrector-potentiator co...
Location
Multiple Locations
Organoid Study R334W
NAIn contrary to what is seen in FRT cells, rectal organoids of patients with...
Location
University Hospital of Leuven
Combined Effect of CFTR Protein Modulator Drugs and Exercise in Cystic Fibrosis
NAThis study aims to assess the effects of programmed exercise combined with ...
Location
Escuela de Doctorado e Investigacion, Universidad Europea